FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy

VC: PregLem gains $26M

Tools


PregLem gains $26M

VENTURE CAPITAL

COMPANY

AMOUNT/ROUND

LEAD INVESTORS

DESCRIPTION

PregLem
Switzerland

$26M
First

Sofinnova Partners

PregLem has programs for gynecological conditions and infertility.

Kiadis Pharma
Amsterdam

$20.16M

Alta Partners

Kiadis is developing therapies for bone marrow transplants and the treatment of aggressive cancers.


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FierceBiotech Email Newsletter:

More stories about pharmaceuticals   Cancer   Switzerland   Biotech Venture Capital